Menopause and the pelvic floor

Menopause represents a physiological stage in a woman's life, associated with the permanent cessation of ovarian hormonal activity and a decline in estrogen production. These changes exert a significant impact on many body systems, including the pelvic floor structures, which are responsible for supporting the pelvic organs and controlling the functions of micturition and defecation. The decrease in sex hormone levels leads to a gradual degradation of soft tissue quality, a reduction in their elasticity, and a weakening of muscle function. Consequently, there is an increased risk of disorders of pelvic organ statics, urinary incontinence, and pain symptoms, which significantly affect the quality of life.

Menopause and the pelvic floor – the impact of estrogens

Estrogens play a key role in maintaining the structural and functional integrity of pelvic floor tissues. Their action includes muscles as well as connective tissue, mucous membranes, and the vascular system.

At the cellular level, estrogens:

stimulate the synthesis of collagen and elastin, responsible for tissue elasticity,
improve blood supply by affecting microcirculation,
increase hydration and trophism of mucous membranes,
support the function of nerve receptors responsible for micturition control.

During menopause, there is a rapid decline in estrogen levels, which results in:

atrophy of the vaginal and urethral epithelium (urogenital atrophy),
a decrease in pelvic floor muscle tone,
weakening of the ligamentous structures supporting the organs,
deterioration of tissue regenerative capacity.

These changes are progressive and cumulative in nature, meaning that over time, the risk of pelvic floor dysfunction significantly increases. It is worth emphasizing that estrogens also affect the function of the lower urinary tract, which explains the more frequent occurrence of urological symptoms in postmenopausal women.

Menopause and the pelvic floor – what changes occur

Changes occurring within the pelvic floor during menopause involve both the muscular component and the fascial and organ components. This process is multifactorial and affects the entire complex of structures that stabilize the pelvis.

The most important changes include:

1. Muscular changes:

reduction in the mass and strength of the pelvic floor muscles,
impaired ability to generate adequate tension,
impaired muscle coordination.

2. Changes in connective tissue:

degradation of collagen fibers,
decreased elasticity of the fascia,
weakening of the ligamentous apparatus.

3. Changes in pelvic organs:

descent of the bladder, uterus, or rectum,
increased mobility of the urethra,
reduced volume and elasticity of the vagina.

4. Vascular and neural changes:

impaired blood supply to the tissues,
decreased receptor sensitivity,
impaired nerve conduction.

The consequence of the above changes is a gradual disruption of biomechanical balance within the pelvis. The pelvic floor ceases to effectively compensate for increases in intra-abdominal pressure, which leads to the appearance of clinical symptoms, especially during physical exertion, coughing, or sneezing.

Menopause and the pelvic floor – symptoms

Symptoms of pelvic floor dysfunction during menopause are varied and often develop gradually. Their nature depends on the severity of the changes and the individual predispositions of the patient.

The most commonly observed are:

Urological symptoms:

stress urinary incontinence,
urinary urgency,
frequent urination,
a feeling of incomplete bladder emptying.

Gynecological symptoms:

a feeling of "heaviness" or of a foreign body in the vagina,
descent or prolapse of the pelvic organs,
vaginal dryness and discomfort during intercourse (dyspareunia).

Proctological symptoms:

difficulties with bowel movements,
a feeling of incomplete bowel emptying,
episodes of gas or stool incontinence.

Pain and functional symptoms:

chronic pelvic pain,
discomfort in the lower abdomen,
reduced sexual quality of life.

It is worth noting that these symptoms often coexist and exacerbate one another. Patients may downplay the complaints for a long time, treating them as a "natural part of aging," which delays the initiation of effective therapy.

Menopause and the pelvic floor – how to prevent complications

Prevention and early intervention are key elements in limiting the negative impact of menopause on the pelvic floor. Management should be multidirectional and include both conservative measures and – in selected cases – medical procedures.

Basic preventive strategies:

1. Urogynecological physiotherapy:

pelvic floor muscle training (so-called Kegel exercises),
learning proper muscle activation and relaxation,
manual and fascial therapy,
biofeedback and electrostimulation.

2. Lifestyle modification:

maintaining a healthy body weight,
avoiding chronic increased intra-abdominal pressure,
regular physical activity of appropriately selected intensity,
prevention of constipation.

3. Hormonal management:

local estrogen therapy (after medical consultation),
improving the trophic state of mucous membranes and urethral function.

4. Modern methods supporting tissue regeneration:

In clinical practice, technologies supporting the remodeling and tension of pelvic floor tissues are also used, such as:

gynecological laser therapy,
radiofrequency (including microneedle radiofrequency),
procedures stimulating collagen production and improving blood supply.

These methods work by inducing controlled micro-injury, which activates regenerative processes and leads to improvement in tissue quality and function.

5. Interventional treatment:

In advanced cases, surgical treatment is considered, including reconstruction of pelvic floor structures or procedures correcting urinary incontinence.

Therapeutic options used in clinical practice also include:

procedures in the field of aesthetic and regenerative gynecology,
therapies supporting the tone and function of tissues in the intimate areas,
comprehensive urogynecological physiotherapy programs.

An integrated approach, encompassing diagnosis, prevention, and therapy, allows effective limitation of progression and improves the quality of life of women during menopause.